
Carla J. Myers
Examiner (ID: 5220, Phone: (571)272-0747 , Office: P/1634 )
| Most Active Art Unit | 1634 |
| Art Unit(s) | 1655, 1682, 1643, 1609, 1621, 1654, 1807, 1634, 1644 |
| Total Applications | 2312 |
| Issued Applications | 1000 |
| Pending Applications | 336 |
| Abandoned Applications | 987 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19701791
[patent_doc_number] => 12195807
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-14
[patent_title] => Method of treating a cancer patient without the need for a tissue biopsy
[patent_app_type] => utility
[patent_app_number] => 17/831345
[patent_app_country] => US
[patent_app_date] => 2022-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10664
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 168
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17831345
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/831345 | Method of treating a cancer patient without the need for a tissue biopsy | Jun 1, 2022 | Issued |
Array
(
[id] => 18005419
[patent_doc_number] => 20220364185
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => Digital Analysis of Blood Samples to Determine Efficacy of Cancer Therapies for Specific Cancers
[patent_app_type] => utility
[patent_app_number] => 17/826834
[patent_app_country] => US
[patent_app_date] => 2022-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19427
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17826834
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/826834 | Digital analysis of blood samples to determine efficacy of cancer therapies for specific cancers | May 26, 2022 | Issued |
Array
(
[id] => 17867505
[patent_doc_number] => 20220290241
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => PREDICTING EXTRAINTESTINAL MANIFESTATIONS OF INFLAMMATORY BOWEL DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/825580
[patent_app_country] => US
[patent_app_date] => 2022-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 66599
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -70
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17825580
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/825580 | PREDICTING EXTRAINTESTINAL MANIFESTATIONS OF INFLAMMATORY BOWEL DISEASE | May 25, 2022 | Abandoned |
Array
(
[id] => 19543486
[patent_doc_number] => 20240360522
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-31
[patent_title] => IDENTIFYING MICROBIAL SIGNATURES AND GENE EXPRESSION SIGNATURES
[patent_app_type] => utility
[patent_app_number] => 18/287776
[patent_app_country] => US
[patent_app_date] => 2022-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41254
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18287776
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/287776 | IDENTIFYING MICROBIAL SIGNATURES AND GENE EXPRESSION SIGNATURES | Apr 20, 2022 | Pending |
Array
(
[id] => 19249139
[patent_doc_number] => 20240200126
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => PRIMER GROUP AND METHOD FOR DETECTING SINGLE-BASE MUTATIONS
[patent_app_type] => utility
[patent_app_number] => 18/287245
[patent_app_country] => US
[patent_app_date] => 2022-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7416
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18287245
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/287245 | PRIMER GROUP AND METHOD FOR DETECTING SINGLE-BASE MUTATIONS | Apr 19, 2022 | Pending |
Array
(
[id] => 19572254
[patent_doc_number] => 20240376546
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-14
[patent_title] => TARGETS OVEREXPRESSED ON THE SURFACE OF CANCER CELLS
[patent_app_type] => utility
[patent_app_number] => 18/553024
[patent_app_country] => US
[patent_app_date] => 2022-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18380
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 269
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18553024
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/553024 | TARGETS OVEREXPRESSED ON THE SURFACE OF CANCER CELLS | Mar 28, 2022 | Pending |
Array
(
[id] => 17705049
[patent_doc_number] => 20220205055
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => ASSAY FOR THE DIAGNOSIS OF DERMATOPHYTOSIS
[patent_app_type] => utility
[patent_app_number] => 17/654758
[patent_app_country] => US
[patent_app_date] => 2022-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15566
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 173
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17654758
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/654758 | ASSAY FOR THE DIAGNOSIS OF DERMATOPHYTOSIS | Mar 13, 2022 | Pending |
Array
(
[id] => 17673155
[patent_doc_number] => 20220186322
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => MARKER FOR HOMOLOGOUS RECOMBINATION DEFICIENCY, METHOD AND SYSTEM FOR DETECTION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/686428
[patent_app_country] => US
[patent_app_date] => 2022-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34866
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 33103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17686428
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/686428 | MARKER FOR HOMOLOGOUS RECOMBINATION DEFICIENCY, METHOD AND SYSTEM FOR DETECTION THEREOF | Mar 3, 2022 | Abandoned |
Array
(
[id] => 19884388
[patent_doc_number] => 12270082
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-08
[patent_title] => Methods of detecting DNA in a sample
[patent_app_type] => utility
[patent_app_number] => 17/678829
[patent_app_country] => US
[patent_app_date] => 2022-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 19
[patent_no_of_words] => 26495
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 287
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17678829
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/678829 | Methods of detecting DNA in a sample | Feb 22, 2022 | Issued |
Array
(
[id] => 17792556
[patent_doc_number] => 20220251647
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => GENE EXPRESSION SIGNATURES USEFUL TO PREDICT OR DIAGNOSE SEPSIS AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/651579
[patent_app_country] => US
[patent_app_date] => 2022-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19869
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17651579
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/651579 | Gene expression signatures useful to predict or diagnose sepsis and methods of using the same | Feb 17, 2022 | Issued |
Array
(
[id] => 20788801
[patent_doc_number] => 12662706
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-06-23
[patent_title] => Crenolanib for treating FLT3 mutated proliferative disorders associated mutations
[patent_app_type] => utility
[patent_app_number] => 17/667781
[patent_app_country] => US
[patent_app_date] => 2022-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18556
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17667781
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/667781 | Crenolanib for treating FLT3 mutated proliferative disorders associated mutations | Feb 8, 2022 | Issued |
Array
(
[id] => 19051334
[patent_doc_number] => 20240093303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => METHODS AND BIOMARKERS IN CANCER
[patent_app_type] => utility
[patent_app_number] => 18/264314
[patent_app_country] => US
[patent_app_date] => 2022-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28582
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18264314
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/264314 | METHODS AND BIOMARKERS IN CANCER | Feb 3, 2022 | Pending |
Array
(
[id] => 19717619
[patent_doc_number] => 12203143
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-21
[patent_title] => Methods and kits to identify
[patent_app_type] => utility
[patent_app_number] => 17/588196
[patent_app_country] => US
[patent_app_date] => 2022-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 22233
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17588196
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/588196 | Methods and kits to identify | Jan 27, 2022 | Issued |
Array
(
[id] => 18280753
[patent_doc_number] => 20230096225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => CLINICAL PREDICTORS OF WEIGHT LOSS
[patent_app_type] => utility
[patent_app_number] => 17/581335
[patent_app_country] => US
[patent_app_date] => 2022-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26121
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17581335
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/581335 | CLINICAL PREDICTORS OF WEIGHT LOSS | Jan 20, 2022 | Abandoned |
Array
(
[id] => 17673147
[patent_doc_number] => 20220186314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => METHODS FOR DIAGNOSING AND TREATING INFLAMMATORY BOWEL DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/580357
[patent_app_country] => US
[patent_app_date] => 2022-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45483
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17580357
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/580357 | METHODS FOR DIAGNOSING AND TREATING INFLAMMATORY BOWEL DISEASE | Jan 19, 2022 | Abandoned |
Array
(
[id] => 17982976
[patent_doc_number] => 20220349012
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-03
[patent_title] => DNA METHYLATION DIAGNOSTIC TEST FOR BREAST CANCER
[patent_app_type] => utility
[patent_app_number] => 17/561434
[patent_app_country] => US
[patent_app_date] => 2021-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30023
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17561434
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/561434 | DNA METHYLATION DIAGNOSTIC TEST FOR BREAST CANCER | Dec 22, 2021 | Abandoned |
Array
(
[id] => 18972329
[patent_doc_number] => 20240052421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => METHOD OF IDENTIFYING AND TREATING MITOCHONDRIAL SUBTYPE TUMORS
[patent_app_type] => utility
[patent_app_number] => 18/259067
[patent_app_country] => US
[patent_app_date] => 2021-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23360
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -43
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18259067
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/259067 | METHOD OF IDENTIFYING AND TREATING MITOCHONDRIAL SUBTYPE TUMORS | Dec 21, 2021 | Pending |
Array
(
[id] => 17688216
[patent_doc_number] => 20220195508
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => tRNA-Derived Fragments as Disease Biomarkers and Neuropathological Regulators in Alzheimer's Disease
[patent_app_type] => utility
[patent_app_number] => 17/554782
[patent_app_country] => US
[patent_app_date] => 2021-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13947
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17554782
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/554782 | tRNA-Derived Fragments as Disease Biomarkers and Neuropathological Regulators in Alzheimer's Disease | Dec 16, 2021 | Pending |
Array
(
[id] => 17520796
[patent_doc_number] => 20220106645
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => Biomarkers for the Diagnosis of Lung Cancers
[patent_app_type] => utility
[patent_app_number] => 17/551113
[patent_app_country] => US
[patent_app_date] => 2021-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17036
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17551113
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/551113 | Biomarkers for the Diagnosis of Lung Cancers | Dec 13, 2021 | Abandoned |
Array
(
[id] => 19121242
[patent_doc_number] => 11965213
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-23
[patent_title] => Methods of detecting spatial heterogeneity of a biological sample
[patent_app_type] => utility
[patent_app_number] => 17/538406
[patent_app_country] => US
[patent_app_date] => 2021-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 52
[patent_no_of_words] => 104474
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 303
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17538406
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/538406 | Methods of detecting spatial heterogeneity of a biological sample | Nov 29, 2021 | Issued |